Michael R. Rudnick, M.D.
Associate Professor CE of Medicine
Chair, New and Existing Technology Committee, Penn Presbyterian Medical Center
39th and Market Stree
Philadelphia PA
Department: Medicine
Contact information
Presbyterian Medical Center
39th and Market Streets
Medical Office Building
Suite 240
Philadelphia, Pa 19104
39th and Market Streets
Medical Office Building
Suite 240
Philadelphia, Pa 19104
Office: (215) 662-8730
Fax: (215) 243-4686
Fax: (215) 243-4686
Email:
rudnickm@uphs.upenn.edu
rudnickm@uphs.upenn.edu
Links
Penn Kidney Medicine Dialysis Care
Penn's Renal-Electrolyte and Hypertension Division
Renal-Electrolyte and Hypertension Research Interests--Nephrology Clinical Research
Penn Presbyterian Medical Center
Penn Kidney Medicine Dialysis Care
Penn's Renal-Electrolyte and Hypertension Division
Renal-Electrolyte and Hypertension Research Interests--Nephrology Clinical Research
Penn Presbyterian Medical Center
Education:
(Biology)
Dickenson College, 1966.
B.A. (Biology)
LaSalle College, 1968.
M.D.
Hahnemann Medical College, 1972.
Permanent link(Biology)
Dickenson College, 1966.
B.A. (Biology)
LaSalle College, 1968.
M.D.
Hahnemann Medical College, 1972.
Description of Research Expertise
Contrast Media Injury to the KidneyCardiac – Renal Interactions
Description of Clinical Expertise
Acute Kidney InjuriesPrevention of contrast media injury to the kidney
Renal Dysfunction in setting of cardiac disease and heart failure
Renovascular diseases
Kidney stone disease
Advanced Chronic Kidney Disease and management of the dialysis patient
Selected Publications
Rudnick MR., Goldfarb S.: Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. [Review] [31 refs] Reviews in Cardiovascular Medicine 4 Suppl 5: S28-33, 2003.Wang A., Holcslaw T., Bashore TM., Freed MI., Miller D., Rudnick MR., Szerlip H., Thames MD., Davidson CJ., Shusterman N., Schwab SJ.: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.[see comment] Kidney International 57(4): 1675-80, Apr 2000.
Berns JS., Rudnick MR., Cohen RM., Bower JD., Wood BC.: Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease. Kidney International 56(1): 253-60, Jul 1999.
Ermer JC., Boni JP., Cevallos WH., DeCleene S., Burghart P., Rudnick MR., Fruncillo RJ., Berns JS., Cohen RM.: Bromfenac disposition in patients with impaired kidney function. Clinical Pharmacology & Therapeutics 61(3): 312-8, Mar 1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [150 refs] Seminars in Nephrology 17(1): 15-26, Jan 1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [83 refs] Current Opinion in Nephrology & Hypertension 5(2): 127-33, Mar 1996.
Berns JS., Haghighat A., Staddon A., Cohen RM., Schmidt R., Fisher S., Rudnick MR., Tomaszewski JE.: Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients. Cancer 76(3): 497-500, Aug 1 1995.
Rudnick MR., Goldfarb S., Wexler L., Ludbrook PA., Murphy MJ., Halpern EF., Hill JA., Winniford M., Cohen MB., VanFossen DB.: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney International 47(1): 254-61, Jan 1995.
Revicki DA., Brown RE., Feeny DH., Henry D., Teehan BP., Rudnick MR., Benz RL.: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. American Journal of Kidney Diseases 25(4): 548-54, Apr 1995.
Roth D., Smith RD., Schulman G., Steinman TI., Hatch FE., Rudnick MR., Sloand JA., Freedman BI., Williams WW Jr., Shadur CA., et al.: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. American Journal of Kidney Diseases 24(5): 777-84, Nov 1994.